News

AddToAny

Google+ Facebook Twitter Twitter

Targeting cells that contribute to ageing-related diseases

Ageing, or senescent cells, which stop dividing but don’t die, can accumulate in the body over the years and fuel chronic inflammation that contributes to conditions such as cancer and degenerative disorders.

In mice, eliminating senescent cells from ageing tissues can restore tissue balance and lead to an increased healthy lifespan.

Now a team led by investigators at Massachusetts General Hospital (MGH), has found that the immune response to a virus that is ubiquitously present in human tissues can detect and eliminate senescent cells in the skin.

The scientists analysed young and old human skin samples to learn more about the clearance of senescent cells in human tissue.

They found more senescent cells in the old skin compared with young skin samples. However, in the samples from old individuals, the number of senescent cells did not increase as individuals got progressively older, suggesting that some type of mechanism kicks in to keep them in check.

Experiments suggested that once a person becomes elderly, certain immune cells called killer CD4+ T cells are responsible for keeping senescent cells from increasing. Higher numbers of killer CD4+ T cells in tissue samples were associated with reduced numbers of senescent cells in old skin.

When they assessed how killer CD4+ T cells keep senescent cells in check, the researchers found that ageing skin cells express a protein, or antigen, produced by human cytomegalovirus, a pervasive herpesvirus that establishes lifelong latent infection in most humans without any symptoms.

By expressing this protein, senescent cells become targets for attack by killer CD4+ T cells.

bit.ly/40mSNgt

Image Credit | SPL

Related Articles

melanoma cell - CREDIT - science-photolibrary-f0403499

Phenotypic plasticity in melanoma: the impact on management strategies

Dr Ghada Elayat looks at the role of epithelial–mesenchymal transition in cancer and the implications for melanoma development.

A.I., Chat with AI, Artificial Intelligence-CREDIT-iStock-1494073860

AI search engines put to the test

Four proposed state-of-the-art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, US research suggests.

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Top